Jarmila Králová

2.3k citations
83 papers · 2.0k indexed · h-index 28

Jarmila Králová

82 papers receiving 2.0k citations

Peers

Jarmila Králová
Comparison fields: 5 of 114
  • Biochemistry 98
  • Molecular Biology 1.0k
  • Cancer Research 206
  • Pulmonary and Respiratory Medicine 394
  • Immunology 215
Replace Marzia Bruna Gariboldi with:
Marzia Bruna Gariboldi Italy
Hyo Jin Kang South Korea
Liqian Gao China
Benoît Paquette Canada
Kenneth M. Tramposch United States
Wim F. A. Steelant United States
Weier Bao China
Longguang Tang China
Jürgen Thomale Germany
Feifei An China
Jarmila Králová relative to Marzia Bruna Gariboldi Italy Marzia Bruna Gariboldi's profile →
Citations per field
00.5×2.8×
Marzia Bruna Gariboldi · 1×
Citations per year

Countries citing papers authored by Jarmila Králová

Since Specialization
Citations

This map shows the geographic impact of Jarmila Králová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jarmila Králová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jarmila Králová more than expected).

Fields of papers citing papers by Jarmila Králová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jarmila Králová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jarmila Králová. The network helps show where Jarmila Králová may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jarmila Králová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jarmila Králová Line = papers co-authored together Jarmila Králová links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 202118
2 202011
3 201912
4 20191
5 201814
6 201722
7 20148
8 201283
9 20106
10 200721
11 200630
12 200641
13 200210
14 200236
15 200119
16 199955
17 199834
18 199511
19 19921
20 19883

About Jarmila Králová

Jarmila Králová is a scholar working on Biophysics, Molecular Biology and Immunology, having authored 83 papers that have together received 2.0k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (16 papers), Porphyrin and Phthalocyanine Chemistry (13 papers), Nanoplatforms for cancer theranostics (9 papers), DNA and Nucleic Acid Chemistry (6 papers), Advanced biosensing and bioanalysis techniques (6 papers), Luminescence and Fluorescent Materials (6 papers), NF-κB Signaling Pathways (6 papers) and Molecular Sensors and Ion Detection (6 papers). The work is most often cited by research in Biochemistry (98 citations), Molecular Biology (1.0k citations) and Cancer Research (206 citations). Jarmila Králová has collaborated with scholars based in Czechia, United States and Russia. Frequent co-authors include Vladimı́r Král, Pavel Martásek, Zdeněk Kejík, Michal Dvořák, Tomáš Břı́za, P Poučková, Michael W. McBurney, M.A. Christine Pratt, Irena Moserová and Henry R. Bose. Their work appears in journals such as Oncogene, Scientific Reports, Bioorganic Chemistry, Journal of Medicinal Chemistry and Physiological Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026